Atlas Trials

Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV

Clinical trial NCT05205083 · UNKNOWN

Trial details

NCT number
NCT05205083
Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2021-11-10
Primary completion
2022-03-01
Enrollment
480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.